SOLV - Solventum Corp Stock Analysis
Solventum Corp (SOLV) is a publicly traded company listed on the NYSE. It operates in the Medical Instruments & Supplies industry, part of the broader Healthcare sector. The company has a market capitalization of 13.12B, generates annual revenue of 8.42B, and reports net income of 1.52B. As of the latest data, the stock is trading at 75.66 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock may be undervalued based on its earnings, though it could also reflect market concerns. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. This stock does not currently pay a dividend. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Hold (3.62), indicating current market sentiment. Institutional ownership is reported at 72.20%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 7.02%, trading within a 52-week range of 60.70 - 85.92.
SOLV - Solventum Corp
75.66
Analyst Consensus
Hold 3.62
SOLV – Analyst Rating Summary
- Strong Buy: 4
- Buy: 6
- Hold: 10
- Sell: 1
- Strong Sell: 0
- Total Analysts: 21
| Index: | S&P 500 | P/E: | 8.71 | EPS (ttm): | 8.69 | Insider Own: | 14.88% | Shs Outstand: | 173.44M | Perf Week: | 5.79% |
| Market Cap: | 13.12B | Forward P/E: | 11.92 | EPS next Y: | 6.35 | Insider Trans: | -25.43% | Shs Float: | 147.64M | Perf Month: | 5.91% |
| Income(ttm): | 1.52B | PEG: | 8.80 | EPS next Q: | 1.49 | Inst Own: | 72.20% | Short Float: | 3.35% | Perf Quarter: | 6.92% |
| Revenue(ttm): | 8.42B | P/S: | 1.56 | EPS this Y: | -10.28% | Inst Trans: | 3.62% | Short Ratio: | 4.28 | Perf Half Y: | 2.09% |
| Book/sh: | 28.75 | P/B: | 2.63 | EPS next Y: | 5.61% | ROA: | 10.61% | Short Interest: | 4.95M | Perf Year: | 7.02% |
| Cash/sh: | 9.47 | P/C: | 7.99 | EPS next 5Y: | 0.99% | ROE: | 37.25% | 52W Range: | 60.70 - 85.92 | Perf YTD: | 14.53% |
| Dividend Est.: | - | P/FCF: | 262.46 | EPS past 3/5Y: | -31.16% - | ROIC: | 15.04% | 52W High: | 85.92 -11.94% | Beta: | 0.46 |
| Dividend TTM: | - | Quick Ratio: | 1.14 | Sales past 3/5Y: | 0.34% - | Gross Margin: | 57.30% | 52W Low: | 60.70 24.65% | Perf 5Y: | - |
| Dividend Ex-Date: | - | Current Ratio: | 1.50 | EPS Y/Y TTM: | 109.91% | Oper. Margin: | 12.32% | RSI (14): | 65.28 | Volatility: | 2.66% 2.37% |
| Employees: | 22000 | Debt/Eq: | 1.03 | Sales Y/Y TTM: | 2.53% | Profit Margin: | 18.08% | Recom: | 2.53 | Target Price: | 84.11 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 1.03 | EPS Q/Q: | 928.76% | Payout: | 0.00% | Rel Volume: | 0.91 | Prev Close: | 75.22 |
| Sales Surprise: | 1.96% | EPS Surprise: | 4.89% | Sales Q/Q: | 0.67% | Earnings: | Nov 06 AMC | Avg Volume: | 1.16M | Price: | 75.66 |
| SMA20: | 6.13% | SMA50: | 4.88% | SMA200: | 3.96% | Undervalued: 11.17% | Volume: | 1,053,814 | Change: | 0.58% | |
Graham Classic formula value: 81.78
(P/E=8 * 1g) Min value: 70.15
(current P/E * 2g) Max value: 83.42
Average value: 78.45
About Solventum Corp
Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.